Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

SWOG 1320, A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) And Trametininb (NSC-763093) in BRAFV600E/K MUTANT MELANOMA


Collapse Overview 
Collapse sponsor award id
SWOG1320


Collapse Biography 

Collapse Time 
Collapse start date
2015-04-24